DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in MRK — Merck & Co., Inc.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$193,622,900
-$11,492,959 QoQ
Shares Held
1,506,793
-11.6% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#137
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Jun 30, 2022CallValue
$13,675,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,628,918,596 across 11 Drug Manufacturers - General names. MRK ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
11,720,479 | $2,222,437,225 | |
| 2 | LLY |
ELI LILLY & Co
|
1,338,915 | $1,605,934,947 | |
| 3 | JNJ |
Johnson & Johnson
|
5,378,305 | $1,365,928,118 | |
| 4 | ABBV |
AbbVie Inc.
|
2,885,557 | $726,121,560 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,628,110 | $332,035,416 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
1,506,793 | $193,622,900 | |
| 7 | AMGN |
Amgen Inc
|
278,356 | $100,798,272 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
895,583 | $51,603,492 |
All Filings in MRK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,622,900 | 1,506,793 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $205,115,859 | 1,705,178 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $183,545,226 | 1,743,732 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $124,534,994 | 1,483,796 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $106,304,436 | 1,342,906 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $110,747,411 | 1,233,817 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $87,063,998 | 875,191 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $566,454,877 | 4,988,155 | Shares | Sole | 2026-05-04 | |
| 2024-06-30 | $1,969,191,518 | 15,906,232 | Shares | Sole | 2026-05-04 | |
| 2024-03-31 | $1,941,334,559 | 14,712,653 | Shares | Sole | 2026-05-04 | |
| 2023-12-31 | $1,315,077,512 | 12,062,718 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $1,215,852,572 | 11,810,127 | Shares | Sole | 2026-05-04 | |
| 2023-06-30 | $1,246,149,225 | 10,799,456 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $700,388,347 | 6,583,216 | Shares | Defined | 2026-05-04 | |
| 2022-12-31 | $835,368,953 | 7,529,238 | Shares | Defined | 2026-05-04 | |
| 2022-09-30 | $675,624,401 | 7,845,151 | Shares | Defined | 2026-05-04 | |
| 2022-06-30 | $416,029,038 | 4,563,223 | Shares | Defined | 2026-05-04 | |
| 2022-06-30 | $13,675,500 | 150,000 | Call | Defined | 2026-05-04 | |
| 2022-03-31 | $147,186,457 | 1,793,863 | Shares | Defined | 2026-05-04 | |
| 2021-12-31 | $138,243,306 | 1,803,801 | Shares | Defined | 2026-05-04 | |
| 2021-09-30 | $199,811,375 | 2,660,250 | Shares | Defined | 2026-05-04 | |
| 2021-06-30 | $337,780,228 | 4,343,323 | Shares | Defined | 2026-05-04 | |
| 2021-03-31 | $111,871,601 | 1,451,181 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $142,481,462 | 1,741,828 | Shares | Defined | 2026-05-04 | |
| 2020-09-30 | $155,646,866 | 1,876,393 | Shares | Defined | 2026-05-04 | |
| 2020-06-30 | $145,033,402 | 1,875,512 | Shares | Defined | 2026-05-04 | |
| 2020-03-31 | $429,060,267 | 5,576,559 | Shares | Defined | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||